(Q39864467)

15 September 2017

title

Highly selective apoptotic cell death induced by halo-salane titanium complexes (English)

1 reference

15 September 2017

0 references

0 references

5

1 reference

15 September 2017

Timo A Immel

1

1 reference

15 September 2017

Malgorzata Debiak

series ordinal

2

1 reference

15 September 2017

Ulrich Groth

series ordinal

3

1 reference

15 September 2017

Alexander Bürkle

series ordinal

4

1 reference

15 September 2017

publication date

1 May 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

4

1 reference

15 September 2017

issue

5

1 reference

15 September 2017

page(s)

738-741

1 reference

Antitumour metallocenes: structure-activity studies and interactions with biomolecules

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

Anti-proliferative activity and mechanism of action of titanocene dichloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Platinum Compounds: a New Class of Potent Antitumour Agents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Synthesis, structure, and antitumor activity of a novel tetranuclear titanium complex

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Non platinum metal complexes as anti-cancer drugs

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Bioorganometallic fulvene-derived titanocene anti-cancer drugs

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Titanocene Dichloride-The First Metallocene with Cancerostatic Activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Antitumor titanium compounds

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Phase II trial of titanocene dichloride in advanced renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Complexes of metals other than platinum as antitumour agents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Titanium complexes in cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Titanium(IV) targets phosphoesters on nucleotides: implications for the mechanism of action of the anticancer drug titanocene dichloride

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Inhibition of human topoisomerase II by the antitumor metallocenes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Calorimetric, spectroscopic, and model studies provide insight into the transport of Ti(IV) by human serum transferrin

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Reconsideration of serum Ti(IV) transport: albumin and transferrin trafficking of Ti(IV) and its complexes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Active Cytotoxic Reagents Based on Non-metallocene Non-diketonato Well-DefinedC2-Symmetrical Titanium Complexes of Tetradentate Bis(phenolato) Ligands

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Single-step synthesis of salans and substituted salans by Mannich condensation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Titanium and zirconium complexes of dianionic and trianionic amine-phenolate-type ligands in catalysis of lactide polymerization

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Achiral tetrahydrosalen ligands for the synthesis of C(2)-symmetric titanium complexes: a structure and diastereoselectivity study

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Comparison of alamar blue and MTT assays for high through-put screening

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Quantification of mitogen induced human lymphocyte proliferation: comparison of alamarBlue assay to 3H-thymidine incorporation assay

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Oxali-Titanocene Y: A Potent Anticancer Drug

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Targeting apoptosis pathways in cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Carbonyl-substituted titanocenes: a novel class of cytostatic compounds with high antitumor and antileukemic activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900038

7 January 2021

Identifiers

DOI

10.1002/CMDC.200900038

1 reference

15 September 2017

1 reference